News
There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...
Merck & Co., Inc. (NYSE:MRK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider from ...
Shares of pharmaceutical company Merck (NYSE: MRK) were recently down about 40% over the past year, partly due to concerns ...
The new project voted ahead by township officials Monday night is planned for roughly a block east, in the Merck campus on ...
The Dow Jones Industrial Average (DJINDICES: ^DJI) index edged 3.9% higher in May, with 70% of its 30 constituent stocks ...
Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC’s Advisory Committee on Immunization Practices on ...
Explore more
Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...
Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...
Protein deficiency is rare in the United States, but some people are at risk for it. Learn the symptoms of protein deficiency ...
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
2d
Stocktwits on MSNMerck Gets FDA Approval For Keytruda To Treat A Broader Population Of Head And Neck Cancer Patients: Retail Stays BullishMerck (MRK) on Friday said that the U.S. Food and Drug Administration (FDA) has approved its blockbuster drug Keytruda for ...
Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results